vorasidenib
servier
['vorasidenib', 'indigo']
first presentation of the #asco23 plenary session starts off with a practice-changing #indigo trial establishing the role of vorasidenib for the treatment of glioma. important results that are based on key pre-clinical work establishing the role of 2-hydroxyglutarate as an 
PGY-2 @BrighamMedRes | @USJLiban MSc '16 MD '18 | @DanaFarber Research '21 | @ASCO #IMG CoP & #JCOCCI Editorial Board | Cancer Genomics |
FCOI: https://t.co/dYsEwGGqP1